|
Orthologous residues
|
|
Lyn (human): Y397‑p, Lyn iso2 (human): Y376‑p, Lyn (mouse): Y397‑p, Lyn iso2 (mouse): Y376‑p, Lyn (rat): Y397‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
phospho-antibody, western blotting
|
|
Relevant cell lines - cell types - tissues:
natural killer cell-blood
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
fibronectin, phorbol ester
|
|
HS1 (human)
|
|
increase
|
|
|
siRNA
|
fibronectin, phorbol ester
|
|
HS1 (human)
|
inhibit treatment-induced increase
|
HS1 siRNA
|
|
ICAM-1, phorbol ester
|
|
HS1 (human)
|
|
increase
|
|
|
siRNA
|
ICAM-1, phorbol ester
|
|
HS1 (human)
|
inhibit treatment-induced increase
|
HS1 siRNA
|
|
|
|